US Patent 7718643 Pharmaceutical formulation
Patent 7718643 was granted and assigned to Schering on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+363 characters)
Article
Patent abstract
The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Wing-Kee Philip Cho0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718643 Pharmaceutical formulation US Patent 7718643 Pharmaceutical formulation
Infobox
Patent Number
07718643
Patent Number
7718643
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718643 Pharmaceutical formulation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718643
Date of patent
May 18, 2010
Patent application number
12472021
Date Filed
May 26, 2009
Patent primary examiner
Find more entities like US Patent 7718643 Pharmaceutical formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
